Hepatitis Monthly

Published by: Neoscriber Demo Publisher

Commentaries and points of view 2

Kamran chairman@hepmon.ir 1 , * and Seyed Moayed Alavian 2
Authors Information
1 Namazi hospital, Shiraz, Fars, IR.Iran
2 Associate professor of gastroenterology and hepatology, Baqiyatallah University of Medical Sciences, Tehran, Tehran, IR.Iran
Article information
  • Hepatitis Monthly: December 31, 2004, 4 (8); e93016
  • Published Online: September 30, 2004
  • Article Type: Commentaries
  • Received: May 06, 2019
  • Accepted: September 30, 2004

To Cite: chairman@hepmon.ir K, Alavian S M. Commentaries and points of view 2, Hepat Mon. 2004 ; 4(8):e93016.

© 2004, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
  • 1. Marcellin P, Lau GK, Bonino F, Farci P, Hadziyannis S, Jin R, Lu ZM, Piratvisuth T, Germanidis G, Yurdaydin C, Diago M, Gurel S, Lai MY, Button P, Pluck N; Peginterferon Alfa-2a HBeAg-Negative Chronic Hepatitis B Study Group. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B. N Engl J Med. 2004; 351:1206-17.
  • 2. Lampertico P, Del Ninno E, Manzin A, Donato MF, Rumi MG, Lunghi G, et al. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum. Hepatology 1997; 26:1621-5.
  • 3. Lampertico P, Del Ninno E, Vigano M, et al.: Long term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy. Hepatology 2003, 37:756-763.
  • 4. Papatheodoridis GV, Hadziyannis SJ. Review article: current management of chronic hepatitis B. Aliment Pharmacol Ther. 2004; 19:25-37.
  • 5. Kao JH; Wu NH; Chen PJ; Lai MY; Chen DS. Hepatitis B genotypes and the response to interferon therapy. J Hepatol 2000; 33:998-1002.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments